{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:10:40Z","timestamp":1774030240611,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2014,4,5]],"date-time":"2014-04-05T00:00:00Z","timestamp":1396656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00213-014-3493-6","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T07:10:29Z","timestamp":1396595429000},"page":"3119-3129","source":"Crossref","is-referenced-by-count":28,"title":["Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse"],"prefix":"10.1007","volume":"231","author":[{"given":"Ra\u00fal","family":"L\u00f3pez-Arnau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mart\u00ednez-Clemente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Abad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pubill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Camarasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Escubedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,5]]},"reference":[{"key":"3493_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0091-3057(88)90155-4","volume":"29","author":"G Battaglia","year":"1988","unstructured":"Battaglia G, Yeh SY, De Souza EB (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29:269\u2013274","journal-title":"Pharmacol Biochem Behav"},{"key":"3493_CR2","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","volume":"37","author":"MH Baumann","year":"2012","unstructured":"Baumann MH, Ayestas MA, Partilla JS, Sink JR, Shulgin AT, Daley PF, Brandt SD, Rothman RB, Ruoho AE, Cozzi NV (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37:1192\u20131203","journal-title":"Neuropsychopharmacology"},{"key":"3493_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.11.020","volume":"698","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR (2013) Psychoactive \"bath salts\": not so soothing. Eur J Pharmacol 698:1\u20135","journal-title":"Eur J Pharmacol"},{"key":"3493_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.annemergmed.2012.01.005","volume":"60","author":"HA Borek","year":"2012","unstructured":"Borek HA, Holstege CP (2012) Hyperthermia and multiorgan failure after abuse of \"bath salts\" containing 3,4-methylenedioxypyrovalerone. Ann Emerg Med 60:103\u2013105","journal-title":"Ann Emerg Med"},{"key":"3493_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/13556210500350794","volume":"10","author":"MG Bossong","year":"2005","unstructured":"Bossong MG, Van Dijk JP, Niesink RJ (2005) Methylone and mCPP, two new drugs of abuse? Addict Biol 10:321\u2013323","journal-title":"Addict Biol"},{"key":"3493_CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13181-011-0159-1","volume":"8","author":"C Boulanger-Gobeil","year":"2012","unstructured":"Boulanger-Gobeil C, St-Onge M, Lalibert\u00e9 M, Auger PL (2012) Seizures and hyponatremia related to ethcathinone and methylone poisoning. J Med Toxicol 8:59\u201361","journal-title":"J Med Toxicol"},{"key":"3493_CR7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/dta.155","volume":"2","author":"SD Brandt","year":"2010","unstructured":"Brandt SD, Sumnall HR, Measham F, Cole J (2010) Analyses of second generation \u201clegal highs\u201d in the UK: initial findings. Drug Test Anal 2:377\u2013382","journal-title":"Drug Test Anal"},{"key":"3493_CR8","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1177\/0269881110378370","volume":"25","author":"TM Brunt","year":"2011","unstructured":"Brunt TM, Poortman A, Niesink RJ, Van den Brink W (2011) Instability of the ecstasy market and a new kid on the block: mephedrone. J Psychopharmacol 25:1543\u20131547","journal-title":"J Psychopharmacol"},{"key":"3493_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2001-15180","volume":"34","author":"G Calapai","year":"2001","unstructured":"Calapai G, Crupi A, Firenzuoli F, Inferrera G, Squadrito F, Parisi A, De Sarro G, Caputi A (2001) Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. Pharmacopsychiatry 34:45\u201349","journal-title":"Pharmacopsychiatry"},{"key":"3493_CR10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.105.092577","volume":"316","author":"JP Capela","year":"2006","unstructured":"Capela JP, Meisel A, Abreu AR, Branco PS, Ferreira LM, Lobo AM, Remi\u00e3o F, Bastos ML, Carvalho F (2006) Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. J Pharmacol Exp Ther 316:53\u201361","journal-title":"J Pharmacol Exp Ther"},{"key":"3493_CR11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jat\/bks046","volume":"36","author":"BM Cawrse","year":"2012","unstructured":"Cawrse BM, Levine B, Jufer RA, Fowler DR, Vorce SP, Dickson AJ, Holler JM (2012) Distribution of methylone in four postmortem cases. J Anal Toxicol 36:434\u2013439","journal-title":"J Anal Toxicol"},{"key":"3493_CR12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.neuropharm.2006.05.032","volume":"51","author":"C Chipana","year":"2006","unstructured":"Chipana C, Camarasa J, Pubill D, Escubedo E (2006) Protection against MDMA-induced dopaminergic neurotoxicity in mice by methyllycaconitine: involvement of nicotinic receptors. Neuropharmacology 51:885\u2013895","journal-title":"Neuropharmacology"},{"key":"3493_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(99)00538-5","volume":"381","author":"NV Cozzi","year":"1999","unstructured":"Cozzi NV, Sievert MK, Shulgin AT, Jacob P, Ruoho AE (1999) Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol 381:63\u201369","journal-title":"Eur J Pharmacol"},{"key":"3493_CR14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2012.10.006","volume":"103","author":"B Hollander den","year":"2013","unstructured":"den Hollander B, Rozov S, Linden AM, Uusi-Oukari M, Ojanper\u00e4 I, Korpi ER (2013) Long-term cognitive and neurochemical effects of \"bath salt\" designer drugs methylone and mephedrone. Pharmacol Biochem Behav 103:501\u2013509","journal-title":"Pharmacol Biochem Behav"},{"key":"3493_CR15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0306-4522(93)90380-X","volume":"54","author":"M Eddleston","year":"1993","unstructured":"Eddleston M, Mucke L (1993) Molecular profile of reactive astrocytes\u2014implications for their role in neurologic disease. Neuroscience 54:15\u201336","journal-title":"Neuroscience"},{"key":"3493_CR16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1124\/jpet.105.089748","volume":"315","author":"E Escubedo","year":"2005","unstructured":"Escubedo E, Chipana C, P\u00e9rez-Sanchez M, Camarasa J, Pubill D (2005) Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors. J Pharmacol Exp Ther 315:658\u2013667","journal-title":"J Pharmacol Exp Ther"},{"key":"3493_CR17","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","volume":"85","author":"AJ Eshleman","year":"2013","unstructured":"Eshleman AJ, Wofrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A (2013) Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85:1803\u20131815","journal-title":"Biochem Pharmacol"},{"key":"3493_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00213-002-1261-5","volume":"166","author":"WE Fantigrossi","year":"2003","unstructured":"Fantigrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH (2003) Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine (\"ecstasy\") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology (Berl) 166:202\u2013211","journal-title":"Psychopharmacology (Berl)"},{"key":"3493_CR19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","volume":"47","author":"AE Fleckenstein","year":"2007","unstructured":"Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR (2007) New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681\u2013698","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3493_CR20","unstructured":"Food and Drug Administration Center for Drug Evaluation and Research (CDER) (2005) Guidance for industry. Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. http:\/\/www.fda.gov\/cder\/guidance\/index.htm . Last accessed May 14, 2013."},{"key":"3493_CR21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/syn.20466","volume":"62","author":"N Granado","year":"2008","unstructured":"Granado N, Escobedo I, O\u2019Shea E, Colado I, Moratalla R (2008) Early loss of dopaminergic terminals in striosomes after MDMA administration to mice. Synapse 62:80\u201384","journal-title":"Synapse"},{"key":"3493_CR22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1124\/jpet.111.184119","volume":"339","author":"GC Hadlock","year":"2011","unstructured":"Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, Andrenyak DM, Vieira-Brock PL, German CL, Conrad KM, Hoonakker AJ, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE (2011) 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339:530\u2013536","journal-title":"J Pharmacol Exp Ther"},{"key":"3493_CR23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-1759(89)90397-9","volume":"119","author":"MB Hansen","year":"1989","unstructured":"Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth\/cell kill. J Immunol Methods 119:203\u2013210","journal-title":"J Immunol Methods"},{"key":"3493_CR24","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/dta.210","volume":"3","author":"L Karila","year":"2010","unstructured":"Karila L, Reynaud M (2010) GHB and synthetic cathinones: clinical effects and potential consequences. Drug Test Anal 3:552\u2013559","journal-title":"Drug Test Anal"},{"key":"3493_CR25","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1476-5381.2011.01499.x","volume":"164","author":"J Kehr","year":"2011","unstructured":"Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F, Yoshitake T (2011) Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats. Br J Pharmacol 164:1949\u20131958","journal-title":"Br J Pharmacol"},{"key":"3493_CR26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(88)90717-0","volume":"152","author":"BJ Logan","year":"1988","unstructured":"Logan BJ, Laverty R, Sanderson WD, Yee YB (1988) Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. Eur J Pharmacol 152:227\u2013234","journal-title":"Eur J Pharmacol"},{"key":"3493_CR27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1476-5381.2012.01998.x","volume":"167","author":"R L\u00f3pez-Arnau","year":"2012","unstructured":"L\u00f3pez-Arnau R, Mart\u00ednez-Clemente J, Pubill D, Escubedo E, Camarasa J (2012) Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol 167:407\u2013420","journal-title":"Br J Pharmacol"},{"key":"3493_CR28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pnpbp.2013.04.007","volume":"45","author":"R L\u00f3pez-Arnau","year":"2013","unstructured":"L\u00f3pez-Arnau R, Mart\u00ednez-Clemente J, Carb\u00f3 M, Pubill D, Escubedo E, Camarasa J (2013) An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as \"bath salts\". Prog Neuropsychopharmacol Biol Psychiatry 45:64\u201372","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3493_CR29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euroneuro.2011.07.009","volume":"22","author":"J Mart\u00ednez-Clemente","year":"2012","unstructured":"Mart\u00ednez-Clemente J, Escubedo E, Pubill D, Camarasa J (2012) Interaction of mephedrone with dopamine and serotonin targets in rats. Eur Neuropsychopharmacol 22:231\u2013236","journal-title":"Eur Neuropsychopharmacol"},{"key":"3493_CR30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugpo.2010.11.001","volume":"22","author":"K McElrath","year":"2011","unstructured":"McElrath K, O\u2019Neill C (2011) Experiences with mephedrone pre- and post-legislative control: perceptions of safety and sources of supply. Int J Drug Policy 22:120\u2013127","journal-title":"Int J Drug Policy"},{"key":"3493_CR31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-003-1452-8","volume":"168","author":"IS McGregor","year":"2003","unstructured":"McGregor IS, Gurtman CG, Morley KC, Clemens KJ, Blokland A, Li KM, Cornish JL, Hunt GE (2003) Increased anxiety and \"depressive\" symptoms months after MDMA (\"ecstasy\") in rats: drug-induced hyperthermia does not predict long-term outcomes. Psychopharmacology (Berl) 168:465\u2013474","journal-title":"Psychopharmacology (Berl)"},{"key":"3493_CR32","first-page":"409","volume":"7","author":"CP Motbey","year":"2011","unstructured":"Motbey CP, Hunt GE, Bowen MT, Artiss S, McGregor IS (2011) Mephedrone (4-methylmethcathinone, 'meow'), acute behavioural effects and distribution of Fos expression in adolescent rats. Addict Biol 7:409\u2013422","journal-title":"Addict Biol"},{"key":"3493_CR33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1124\/jpet.112.201699","volume":"344","author":"M Mueller","year":"2013","unstructured":"Mueller M, Maldonado-Adrian C, Yuan J, McCann UD, Ricaurte GA (2013) Studies of (\u00b1)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile. J Pharmacol Exp Ther 344:479\u2013488","journal-title":"J Pharmacol Exp Ther"},{"key":"3493_CR34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","volume":"559","author":"F Nagai","year":"2007","unstructured":"Nagai F, Nonaka R, Satoh HKK (2007) The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559:132\u2013137","journal-title":"Eur J Pharmacol"},{"key":"3493_CR35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00204-008-0323-9","volume":"83","author":"Y Nakagawa","year":"2009","unstructured":"Nakagawa Y, Suzuki T, Tayama S, Ishii H, Ogata A (2009) Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes. Arch Toxicol 83:69\u201380","journal-title":"Arch Toxicol"},{"key":"3493_CR36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/jat\/bks043","volume":"36","author":"JM Pearson","year":"2012","unstructured":"Pearson JM, Hargraves TL, Hair KLS, Massucci CJ, Frazee CC, Garg U, Pietak BR (2012) Three fatal intoxications due to methylone. J Anal Toxicol 36:444\u2013451","journal-title":"J Anal Toxicol"},{"key":"3493_CR37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","volume":"177","author":"B Petit-Demouliere","year":"2005","unstructured":"Petit-Demouliere B, Chenu F, Bourin M (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 177:245\u2013255","journal-title":"Psychopharmacology (Berl)"},{"key":"3493_CR38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379\u2013391","journal-title":"Eur J Pharmacol"},{"key":"3493_CR39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","volume":"8","author":"JM Prosser","year":"2012","unstructured":"Prosser JM, Nelson LS (2012) The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 8:33\u201342","journal-title":"J Med Toxicol"},{"key":"3493_CR40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0165-3806(93)90201-K","volume":"72","author":"C Pu","year":"1993","unstructured":"Pu C, Vorhees CV (1993) Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Brain Res Dev Brain Res 72:325\u2013328","journal-title":"Brain Res Dev Brain Res"},{"key":"3493_CR41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0028-3908(02)00411-2","volume":"44","author":"V S\u00e1nchez","year":"2003","unstructured":"S\u00e1nchez V, Camarero J, O\u2019Shea E, Green AR, Colado MI (2003) Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats. Neuropharmacology 44:449\u2013461","journal-title":"Neuropharmacology"},{"key":"3493_CR42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/026988110401800312","volume":"18","author":"V S\u00e1nchez","year":"2004","unstructured":"S\u00e1nchez V, O'Shea E, Saadat KS, Elliott JM, Colado MI, Green AR (2004) Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurons. J Psychopharmacol (Berl) 18:412\u2013416","journal-title":"J Psychopharmacol (Berl)"},{"key":"3493_CR43","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0028-3908(92)90126-A","volume":"31","author":"U Scheffel","year":"1992","unstructured":"Scheffel U, Lever JR, Stathis M, Ricaurte GA (1992) Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors. Neuropharmacology 31:881\u2013893","journal-title":"Neuropharmacology"},{"key":"3493_CR44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1024\/0040-5930.64.2.109","volume":"64","author":"C Senn","year":"2007","unstructured":"Senn C, B\u00fccheli A, Schaub M, Stohler R (2007) Club drugs. Ther Umsch 64:109\u2013113","journal-title":"Ther Umsch"},{"key":"3493_CR45","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.pnpbp.2006.06.012","volume":"31","author":"E Shimizu","year":"2007","unstructured":"Shimizu E, Watanabe H, Kojima T, Hagiwara H, Fujisaki M, Miyatake R, Hashimoto K, Iyo M (2007) Combined intoxication with methylone and 5-MeO-MIPT. Prog Neuropsychopharmacol Biol Psychiatry 31:288\u2013291","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3493_CR46","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"LD Simmler","year":"2013","unstructured":"Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME (2013) Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168:458\u2013470","journal-title":"Br J Pharmacol"},{"key":"3493_CR47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/157015911795017425","volume":"9","author":"C Sogawa","year":"2011","unstructured":"Sogawa C, Sogawa N, Ohyama K, Kikura-Hanajiri R, Goda Y, Sora I, Kitayama S (2011) Methylone and monoamine transporters: correlation with toxicity. Curr Neuropharmacol 9:58\u201362","journal-title":"Curr Neuropharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3493-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-014-3493-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3493-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T12:36:37Z","timestamp":1558614997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-014-3493-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,5]]},"references-count":47,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["3493"],"URL":"https:\/\/doi.org\/10.1007\/s00213-014-3493-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,5]]}}}